KRYS short interest

Krystal Biotech · settlement of Oct 30, 2026

Short seller alerts · KRYS · free

Get an email when Krystal Biotech moves

An email when FINRA publishes its short interest, when it files to sell shares, and when its borrow fee passes 10%, 25%, 50% or more a year.

Short seller alerts for KRYS: an email when its short interest is published, when it files to sell shares and when its borrow fee passes 10%, 25%, 50% or more a year. Unsubscribe in one click.

As of Oct 30, 2026, 3.0M KRYS shares were sold short, up 3.7% from the Oct 15, 2026 count. At the stock's average daily volume, that is 12 days to cover.

Krystal Biotech research · KRYS trades by Congress · Short interest movers · Most shorted stocks · Source

Shares sold short
3.0M3,044,878
Change
+3.7%from 2.9M
Of shares outstanding
10.3%#652 of 3,623 stocks measured
Days to cover
12at the average daily volume
Average daily volume
248,952shares, as FINRA reports it
Most in 16 settlements
3.5MJun 30, 2026

Every settlement

16 settlements, newest first
SettlementShares shortChangeAvg daily volumeDays to cover
Oct 30, 20263,044,878+3.7%248,95212
Oct 15, 20262,936,047−15.5%284,20910
Sep 30, 20263,475,527+9.9%310,50211
Sep 15, 20263,163,642−5.5%239,12913
Aug 31, 20263,347,813+4.5%219,24515
Aug 14, 20263,204,909+0.1%310,63610
Jul 31, 20263,202,260−8.4%770,9664.2
Jul 15, 20263,496,648−0.6%307,16011
Jun 30, 20263,517,595+12.1%489,2557.2
Jun 15, 20263,138,292−0.3%288,94511
May 29, 20263,147,863−1.1%194,30516
May 15, 20263,183,527+2.8%397,2308.0
Apr 30, 20263,095,771+6.3%225,02014
Apr 15, 20262,912,515−7.2%259,13411
Mar 31, 20263,136,891+8.6%313,29910
Mar 13, 20262,887,556—240,45412

Short seller alerts · KRYS · free

Get an email when Krystal Biotech moves

An email when FINRA publishes its short interest, when it files to sell shares, and when its borrow fee passes 10%, 25%, 50% or more a year.

Short seller alerts for KRYS: an email when its short interest is published, when it files to sell shares and when its borrow fee passes 10%, 25%, 50% or more a year. Unsubscribe in one click.

Cost to borrow

Read 2:02 PM ET, Nov 11, 2026

Borrowing KRYS to sell short costs 0.28% a year at Interactive Brokers, which has 150,000 shares left to lend. The hardest stocks to borrow.

Filings to sell shares

SEC filings since Aug 7, 2026

No filing by KRYS to sell shares in the SEC’s filings from Aug 7, 2026 to Nov 10, 2026. Every company that filed.

Source

Short interest is the number of shares sold short and not yet bought back. Brokers report it to FINRA for two settlement dates a month, the middle and the end, and FINRA publishes each count about a week later. It is not a daily figure: between settlements no one publishes a count. Days to cover is the short interest divided by the average daily volume FINRA reports beside it. A rising count is shown in red and a falling one in green.

Fails to deliver are the shares sellers had not delivered by the settlement date, a balance outstanding on each date, from the SEC’s fails-to-deliver files, published twice a month about two weeks after each half-month ends. The value is the shares times that day’s closing price in the same file. Every security’s fails.

The cost to borrow is Interactive Brokers’ own yearly fee to borrow the stock and the shares it has left to lend, from the file it publishes about every 15 minutes; a weekday’s last read stands for that day. It is one broker’s figure; another’s can differ. The hardest stocks to borrow.

Filings to sell shares are the company’s prospectuses for shares, shelf and other registrations, and 8-Ks reporting a private sale, from the SEC’s daily index of filings, each cover read so that bond offerings are left out. Each form links to the filing. Every listed company that filed.

ScoutJUST THIS STORY

LET’S MAKE THIS USEFUL · 1 OF 5

How would you like me to explain this?

Tell me what you want from this read. Start with a quick note, then adjust the details. Your other stories stay as they are.

We’ll remember your view of this story. The published article stays unchanged.

THIS STORY’S READING VIEWStandard · The whole picture

Clear explanations with context. Both sides of the evidence.